Chemical activators of V1RD22 can initiate a cascade of intracellular events leading to the functional activation of this protein. Forskolin, known for its ability to directly stimulate adenylyl cyclase, results in an elevation of cAMP levels within the cell, which in turn activates protein kinase A (PKA). Once activated, PKA can phosphorylate target proteins such as V1RD22, leading to their activation. Isoproterenol, a beta-adrenergic agonist, similarly raises intracellular cAMP levels, further engaging PKA and promoting the phosphorylation and activation of V1RD22. Another agent, Vardenafil, functions differently by inhibiting phosphodiesterase type 5, which prevents the breakdown of cGMP, thereby increasing its concentration. Elevated cGMP levels activate protein kinase G (PKG), which then can phosphorylate and activate V1RD22. Similarly, IBMX also prevents the breakdown of cAMP by inhibiting phosphodiesterases, thus sustaining PKA activity, which is crucial for the phosphorylation and consequent activation of V1RD22.
Prostaglandin E2 and Histamine, through their interactions with their respective receptors, both culminate in raised cAMP levels, ultimately activating PKA, which is implicated in the activation of V1RD22 via phosphorylation. On another pathway, Sodium Nitroprusside acts by releasing nitric oxide, which stimulates guanylyl cyclase to produce cGMP, activating PKG, leading to the phosphorylation and subsequent activation of V1RD22. Angiotensin II, through the AT1 receptor, activates phospholipase C (PLC), which results in the activation of protein kinase C (PKC), another kinase that can phosphorylate and activate V1RD22. Diacylglycerol, a direct activator of PKC, similarly promotes the phosphorylation and activation of V1RD22. Anisomycin, which activates the JNK signaling pathway, includes kinases that directly phosphorylate and activate V1RD22. Epinephrine and Glucagon, both through their respective receptors, increase cAMP production, setting the stage for PKA-mediated phosphorylation and activation of V1RD22. Each of these chemicals, through their distinct pathways, converge on the activation of V1RD22 by fostering an environment that promotes its phosphorylation and subsequent activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, increases cAMP concentrations, thus activating PKA which could phosphorylate and activate V1RD22. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil inhibits phosphodiesterase type 5, leading to increased cGMP levels which can activate PKG that may phosphorylate and activate V1RD22. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, increasing cAMP levels, and thereby sustaining PKA activity which could phosphorylate and activate V1RD22. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, through its action on H2 receptors, raises cAMP levels, possibly activating PKA to phosphorylate and activate V1RD22. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 interacts with EP receptors to increase cAMP, which can activate PKA and lead to phosphorylation and activation of V1RD22. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium Nitroprusside releases nitric oxide, which stimulates guanylyl cyclase to produce cGMP, activating PKG to phosphorylate and activate V1RD22. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II engages the AT1 receptor, initiating PLC pathway and activation of PKC, which can phosphorylate and activate V1RD22. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
Diacylglycerol activates PKC that could lead to the phosphorylation and subsequent activation of V1RD22. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the JNK signaling pathway, which includes kinases that can directly phosphorylate and activate V1RD22. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, via beta-adrenergic receptors, elevates cAMP levels, which can lead to activation of V1RD22 through PKA phosphorylation. | ||||||